Latest Rofecoxib Stories

A panel of U.S. Food and Drug Administration advisers voted Wednesday to allow GlaxoSmithKline's diabetes drug Avandia to remain on the market, but with new restrictions due to the risky cardiovascular side effects of the controversial pill.The panel of experts voted 20-12 to retain availability of Avandia to diabetics, although 10 panelists called for limiting who can receive and prescribe the once-blockbuster medication.British drugmaker Glaxo has been hit with thousands of lawsuits from...

LOS ANGELES, April 10 /PRNewswire/ -- In selecting U.S. District Judge James V. Selna to hear more than 100 federal lawsuits filed around the country against Toyota, a federal judicial panel also granted a formal request by the Lanier Law Firm to rename the litigation and expand its scope. "We're thrilled," says attorney Mark Lanier, who was recently named one of the decade's most influential lawyers by the National Law Journal. "This is far from merely a mechanical problem. We intend...

HOUSTON, March 3 /PRNewswire/ -- The Lanier Law Firm is announcing a lawsuit filed today in Harris County state district court by the family of a Houston woman who was injured in a crash while driving a Toyota Camry with a defective acceleration control system. Attorney Mark Lanier, founder of The Lanier Law Firm, and Tammy Tran of Houston's The Tammy Tran Law Firm are representing Anna Pham and her mother Natalie Pham in their claims against Toyota Motor Corp. and Auto Spot, the...

MONTGOMERY, Ala., Feb. 23 /PRNewswire/ -- Beasley Allen attorney Graham Esdale is in Washington, DC this week with three adult children of the firm's deceased client Barbara Schwarz. Esdale and clients, Margie Louise Meibergen, Sharon L. Brandt and Julie Brandt Mayfield, will be attending the congressional hearings this week and are willing to speak to the media. The group appeared on the CBS Early Show Tuesday morning and later on CNN. The family of Mrs. Schwarz plans to speak with...

The Food and Drug Administration fell short with drug approvals in 2009 and drug warnings were lacking, even as the FDA's new leadership adopted a tougher attitude on safety, according to the Associated Press. According to investment research group Washington Analysis, the FDA approved 26 new prescriptions last year, up slightly from the year before. Thirty-one new or updated warning labels were added to drugs already on the market. That number is down from 56 warnings the previous year, many...

NEW YORK, Dec. 1 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies http://www.reportlinker.com/p0166813/Direct-to-Consumer-DTC-Advertising-in-Pharmaceuticals---Current-and-Future-Market-Outlook-Regulatory-Landscape-and-Case-Studies.html Summary The author has released its latest research, "Direct to...

Head to Head: Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs?On bmj.com today two experts debate whether the conflict of interest is unacceptable when drug companies carry out clinical trials on their own medicines.Their views come as new guidance on the standards required for communicating company sponsored medical research is published.Vincent Lawton, a healthcare consultant and non-executive director at the Medicines and Healthcare products...

Clinical trial data indicated an association between the anti-inflammatory medication rofecoxib and cardiovascular risk as early as December 2000, before the product was taken off the market in September 2004, according to a report in the November 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.Rofecoxib was introduced to the market in May 1999 and quickly became a commercial success, with sales reaching $2 billion annually, according to background information in...

Provides lessons for post-market pharmaceutical safetyEvidence of cardiovascular risks associated with taking Vioxx, the popular, nonsteroidal anti-inflammatory drug (rofecoxib), could have been identified nearly four years before its manufacturer, Merck & Co. Inc., voluntarily pulled the drug from the market.Led by Joseph Ross, MD, MHS, Assistant Professor of Geriatrics and Palliative Medicine and of Medicine at Mount Sinai School of Medicine, a team of six investigators analyzed 30...

ENGLEWOOD, Colo., Nov. 13 /PRNewswire/ -- On November 10, 2009, Judge David R. Herndon, the federal judge presiding over the Yasmin and Yaz (Drospirenone) Marketing Sales Practices and Product Liability Multidistrict Litigation MDL #2100 in the Southern District of Illinois, appointed Michael S. Burg as one of three Co-Lead Counsel to serve on the Plaintiffs' Steering Committee. The PSC reports directly to Judge Herndon, and is responsible for conducting pre-trial proceedings on behalf of...